Financial Ratios Scientific and Medical Equipment House Company
Stocks
4014
SA15GGQ1UN19
Healthcare Facilities & Services
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.50 SAR | -1.32% |
|
-2.66% | -10.15% |
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
Profitability | |||||||||
Return on Assets | 5.4 | 2.32 | 4.06 | 3.33 | 2.41 | ||||
Return on Total Capital | 7.57 | 3.2 | 5.35 | 4.33 | 3.24 | ||||
Return On Equity % | 16.99 | 3.31 | 7.75 | 6.17 | 5.21 | ||||
Return on Common Equity | 17.2 | 3.72 | 8.17 | 6.42 | 5.58 | ||||
Margin Analysis | |||||||||
Gross Profit Margin % | 21.84 | 21.54 | 16.58 | 15.18 | 13.87 | ||||
SG&A Margin | 10.06 | 10.95 | 11 | 9.45 | 9.22 | ||||
EBITDA Margin % | 13.08 | 6.69 | 9.9 | 7.4 | 5.26 | ||||
EBITA Margin % | 11.78 | 5.18 | 8.37 | 6.27 | 4.17 | ||||
EBIT Margin % | 11.78 | 5.07 | 8.27 | 6.25 | 4.15 | ||||
Income From Continuing Operations Margin % | 10.97 | 2.19 | 4.73 | 3.56 | 2.99 | ||||
Net Income Margin % | 11.08 | 2.46 | 5.01 | 2.98 | 3.24 | ||||
Net Avail. For Common Margin % | 11.08 | 2.46 | 5.01 | 3.74 | 3.24 | ||||
Normalized Net Income Margin | 7.67 | 2.69 | 4.42 | 3.44 | 3.06 | ||||
Levered Free Cash Flow Margin | -18.41 | 13.2 | -24.7 | 27.2 | -2.98 | ||||
Unlevered Free Cash Flow Margin | -17.25 | 14.92 | -22.72 | 29 | -1.9 | ||||
Asset Turnover | |||||||||
Asset Turnover | 0.73 | 0.73 | 0.79 | 0.85 | 0.93 | ||||
Fixed Assets Turnover | 16.22 | 14.13 | 13.4 | 16.2 | 20.04 | ||||
Receivables Turnover (Average Receivables) | 1.12 | 1.08 | 1.13 | 1.24 | 1.33 | ||||
Inventory Turnover (Average Inventory) | 5.96 | 5.75 | 6.58 | 7.15 | 8.93 | ||||
Short Term Liquidity | |||||||||
Current Ratio | 1.99 | 2.21 | 1.97 | 2.41 | 2.44 | ||||
Quick Ratio | 1.61 | 1.78 | 1.64 | 1.95 | 2.1 | ||||
Operating Cash Flow to Current Liabilities | -0.15 | 0.33 | -0.28 | 0.79 | 0.02 | ||||
Days Sales Outstanding (Average Receivables) | 327.05 | 338.31 | 322.04 | 296.29 | 274.3 | ||||
Days Outstanding Inventory (Average Inventory) | 61.27 | 63.52 | 55.48 | 51.22 | 40.86 | ||||
Average Days Payable Outstanding | 39.3 | 43.5 | 32 | 26.13 | 26.5 | ||||
Cash Conversion Cycle (Average Days) | 349.02 | 358.33 | 345.52 | 321.38 | 288.65 | ||||
Long Term Solvency | |||||||||
Total Debt/Equity | 56.21 | 44.08 | 71.6 | 41.22 | 38.24 | ||||
Total Debt / Total Capital | 35.98 | 30.59 | 41.72 | 29.19 | 27.66 | ||||
LT Debt/Equity | 2.74 | 4.33 | 3.92 | 3.13 | 2.51 | ||||
Long-Term Debt / Total Capital | 1.76 | 3 | 2.28 | 2.21 | 1.81 | ||||
Total Liabilities / Total Assets | 53.46 | 49.67 | 54.1 | 46.94 | 46.34 | ||||
EBIT / Interest Expense | 6.36 | 1.84 | 2.61 | 2.17 | 2.41 | ||||
EBITDA / Interest Expense | 7.38 | 2.75 | 3.51 | 2.93 | 3.58 | ||||
(EBITDA - Capex) / Interest Expense | 6.8 | 2.07 | 2.92 | 2.75 | 3.11 | ||||
Total Debt / EBITDA | 2.79 | 3.82 | 4.09 | 2.81 | 3.54 | ||||
Net Debt / EBITDA | 2.31 | 2.81 | 3.9 | 1.62 | 3.16 | ||||
Total Debt / (EBITDA - Capex) | 3.02 | 5.07 | 4.91 | 2.98 | 4.07 | ||||
Net Debt / (EBITDA - Capex) | 2.51 | 3.73 | 4.68 | 1.72 | 3.64 | ||||
Growth Over Prior Year | |||||||||
Total Revenues, 1 Yr. Growth % | 13.28 | 2.05 | 11.97 | 12.95 | -0.06 | ||||
Gross Profit, 1 Yr. Growth % | 1.53 | 0.67 | -13.83 | 3.43 | -8.71 | ||||
EBITDA, 1 Yr. Growth % | -1.79 | -47.82 | 65.75 | -24.43 | -29.38 | ||||
EBITA, 1 Yr. Growth % | -5.11 | -55.09 | 80.69 | -26.41 | -33.48 | ||||
EBIT, 1 Yr. Growth % | -5.11 | -56.1 | 82.82 | -26.47 | -33.63 | ||||
Earnings From Cont. Operations, 1 Yr. Growth % | 3.49 | -79.65 | 142.07 | -33.58 | -16.07 | ||||
Net Income, 1 Yr. Growth % | 3.7 | -77.34 | 128.04 | -34.68 | 8.68 | ||||
Normalized Net Income, 1 Yr. Growth % | 4.35 | -64.16 | 83.75 | -26.56 | -10.94 | ||||
Diluted EPS Before Extra, 1 Yr. Growth % | 3.7 | -77.34 | 128.04 | -33.46 | -13.28 | ||||
Accounts Receivable, 1 Yr. Growth % | 31.54 | -14.18 | 33.04 | -24.74 | 16.05 | ||||
Inventory, 1 Yr. Growth % | 12.66 | 0.45 | 7.53 | -1.74 | -36.2 | ||||
Net Property, Plant and Equip., 1 Yr. Growth % | 3.32 | 30.65 | 8.42 | -25.5 | -10.82 | ||||
Total Assets, 1 Yr. Growth % | 14.44 | -8.53 | 18.58 | -13.79 | -1.93 | ||||
Tangible Book Value, 1 Yr. Growth % | 10.62 | -1.43 | 8.91 | 0.27 | -0.43 | ||||
Common Equity, 1 Yr. Growth % | 10.62 | -0.65 | 8.59 | -0.03 | -0.38 | ||||
Cash From Operations, 1 Yr. Growth % | -161.41 | -272.15 | -195.83 | -303.21 | -96.94 | ||||
Capital Expenditures, 1 Yr. Growth % | -67.58 | 78.38 | 11.99 | -70.25 | 59.92 | ||||
Levered Free Cash Flow, 1 Yr. Growth % | -355.04 | -173.19 | -301.55 | -223.26 | -110.93 | ||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -306.87 | -188.28 | -264.76 | -242.93 | -106.54 | ||||
Dividend Per Share, 1 Yr. Growth % | -33.33 | - | - | 0 | - | ||||
Compound Annual Growth Rate Over Two Years | |||||||||
Total Revenues, 2 Yr. CAGR % | 8.24 | 7.52 | 6.9 | 10.86 | 6.25 | ||||
Gross Profit, 2 Yr. CAGR % | 7.01 | 1.1 | -6.86 | -6.95 | -2.83 | ||||
EBITDA, 2 Yr. CAGR % | 14.07 | -28.42 | -7 | 16.61 | -26.75 | ||||
EBITA, 2 Yr. CAGR % | 11.42 | -34.72 | -9.91 | 21.89 | -30.04 | ||||
EBIT, 2 Yr. CAGR % | 11.42 | -35.46 | -10.41 | 23.12 | -30.14 | ||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 4.41 | -54.11 | -29.82 | 41.43 | -25.34 | ||||
Net Income, 2 Yr. CAGR % | 4.74 | -51.53 | -28.12 | 22.05 | -15.74 | ||||
Normalized Net Income, 2 Yr. CAGR % | 9.84 | -38.85 | -18.85 | 25.28 | -19.23 | ||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 4.74 | -51.53 | -28.12 | 36.63 | -24.03 | ||||
Accounts Receivable, 2 Yr. CAGR % | 8.18 | 6.25 | 6.34 | 0.39 | -6.55 | ||||
Inventory, 2 Yr. CAGR % | 83.45 | 6.38 | 3.93 | 2.79 | -20.82 | ||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 33.88 | 16.18 | 19.02 | -10.12 | -18.49 | ||||
Total Assets, 2 Yr. CAGR % | 8.67 | 2.31 | 4.15 | 1.11 | -8.05 | ||||
Tangible Book Value, 2 Yr. CAGR % | 15.42 | 4.42 | 3.61 | 4.5 | -0.08 | ||||
Common Equity, 2 Yr. CAGR % | 15.34 | 4.83 | 3.87 | 4.19 | -0.2 | ||||
Cash From Operations, 2 Yr. CAGR % | -33.49 | 2.82 | 39.72 | 39.55 | -75.06 | ||||
Capital Expenditures, 2 Yr. CAGR % | -15.92 | -23.95 | 41.34 | -42.28 | -31.03 | ||||
Levered Free Cash Flow, 2 Yr. CAGR % | 22.28 | 36.62 | 23.83 | 56.08 | -63.27 | ||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 10.81 | 35.13 | 22.68 | 51.93 | -69.41 | ||||
Dividend Per Share, 2 Yr. CAGR % | - | - | 22.47 | - | - | ||||
Compound Annual Growth Rate Over Three Years | |||||||||
Total Revenues, 3 Yr. CAGR % | 6.2 | 6.14 | 8.98 | 7.84 | 7.09 | ||||
Gross Profit, 3 Yr. CAGR % | 5.22 | 4.85 | -4.14 | -4.47 | -7.54 | ||||
EBITDA, 3 Yr. CAGR % | 2.08 | -12.11 | -5.3 | -10.81 | -1.16 | ||||
EBITA, 3 Yr. CAGR % | 0.52 | -17.7 | -8.34 | -12.61 | -0.39 | ||||
EBIT, 3 Yr. CAGR % | 0.52 | -18.32 | -8.68 | -12.69 | 0.2 | ||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 3.96 | -39.47 | -20.12 | -25.89 | 18.85 | ||||
Net Income, 3 Yr. CAGR % | 4.43 | -37.12 | -18.78 | -30.37 | 17.42 | ||||
Normalized Net Income, 3 Yr. CAGR % | 4.79 | -24.38 | -11.75 | -17.45 | 11.71 | ||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 4.43 | -37.12 | -18.78 | -24.93 | 17.42 | ||||
Accounts Receivable, 3 Yr. CAGR % | 6.93 | 0.15 | 14.15 | -5.03 | 5.36 | ||||
Inventory, 3 Yr. CAGR % | 57.91 | 50.08 | 6.76 | 2.01 | -12.32 | ||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 57.98 | 32.8 | 13.54 | 1.81 | -10.36 | ||||
Total Assets, 3 Yr. CAGR % | 6.38 | 2.61 | 7.47 | -2.21 | 0.08 | ||||
Tangible Book Value, 3 Yr. CAGR % | 16.42 | 9.5 | 5.9 | 2.48 | 2.83 | ||||
Common Equity, 3 Yr. CAGR % | 16.34 | 9.74 | 6.07 | 2.55 | 2.64 | ||||
Cash From Operations, 3 Yr. CAGR % | -12.78 | -8.68 | 6.23 | 58.3 | -60.94 | ||||
Capital Expenditures, 3 Yr. CAGR % | 35.93 | 8.04 | -13.48 | -15.93 | -18.93 | ||||
Levered Free Cash Flow, 3 Yr. CAGR % | -3.84 | 3.05 | 57.55 | 22.83 | -35.64 | ||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -3.37 | 2.72 | 46.02 | 28.23 | -46.73 | ||||
Dividend Per Share, 3 Yr. CAGR % | - | - | 0 | 14.47 | - | ||||
Compound Annual Growth Rate Over Five Years | |||||||||
Total Revenues, 5 Yr. CAGR % | - | 5.11 | 6.48 | 8 | 7.26 | ||||
Gross Profit, 5 Yr. CAGR % | - | 7.21 | 0.21 | -0.04 | -4.17 | ||||
EBITDA, 5 Yr. CAGR % | - | -4.68 | -1.66 | -1.59 | -13.13 | ||||
EBITA, 5 Yr. CAGR % | - | -7.52 | -3.79 | -3.7 | -15.88 | ||||
EBIT, 5 Yr. CAGR % | - | -7.94 | -4 | -3.75 | -15.96 | ||||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | -20.67 | -11.16 | -15 | -18.78 | ||||
Net Income, 5 Yr. CAGR % | - | -18.69 | -10.06 | -18.02 | -17.58 | ||||
Normalized Net Income, 5 Yr. CAGR % | - | -12.03 | -5.4 | -7.46 | -12.21 | ||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | -18.69 | -10.06 | -14.23 | -17.58 | ||||
Accounts Receivable, 5 Yr. CAGR % | - | 7.34 | 6.69 | 0.05 | 5.51 | ||||
Inventory, 5 Yr. CAGR % | - | 14.87 | 33.58 | 29 | -5.27 | ||||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | 35.24 | 41.06 | 13.6 | -0.56 | ||||
Total Assets, 5 Yr. CAGR % | - | 7.21 | 5.48 | 2.01 | 0.97 | ||||
Tangible Book Value, 5 Yr. CAGR % | - | 13.01 | 11.12 | 7.47 | 3.46 | ||||
Common Equity, 5 Yr. CAGR % | - | 13.11 | 11.18 | 7.49 | 3.51 | ||||
Cash From Operations, 5 Yr. CAGR % | - | 9.74 | 5.31 | 11.91 | -40.5 | ||||
Capital Expenditures, 5 Yr. CAGR % | - | 33.02 | 38.06 | -15.92 | -20.98 | ||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | 6.39 | 22.61 | -12.35 | ||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | 6.31 | 20.96 | -22.17 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















